---
title: "Endologix initiates postmarket study of the Detour system"
date: "2024-03-01T09:28:42.000Z"
publishedDate: "1 mars 2024"
summary: "Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study aimed at evaluating the real-world performance of the Detour system in patients undergoing treatment for long complex superficial femoral artery (SFA) disease."
importance: ""
sourceUrl: "https://vascularnews.com/endologix-initiates-postmarket-study-of-the-detour-system/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-03-01-endologix-initiates-postmarket-study-of-the-detour-system"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/07/PTAB-using-the-Detour-system.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/endologix-initiates-postmarket-study-of-the-detour-system/"
---

![Endologix initiates postmarket study of the Detour system](https://vascularnews.com/wp-content/uploads/sites/7/2023/07/PTAB-using-the-Detour-system.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/endologix-initiates-postmarket-study-of-the-detour-system/*

## L’essentiel

Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study aimed at evaluating the real-world performance of the Detour system in patients undergoing treatment for long complex superficial femoral artery (SFA) disease.

## Lien source

https://vascularnews.com/endologix-initiates-postmarket-study-of-the-detour-system/
